Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. (Q45716180)
Jump to navigation
Jump to search
scientific article published on 8 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. |
scientific article published on 8 March 2011 |
Statements
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease (English)
Bronwen E Shaw
Jane F Apperley
Nigel H Russell
Effie Liakopoulou
Michael N Potter
Brenda Gibson
Rachel M Pearce
Keiren Kirkland
Julia Lee
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference